Thrivent Financial For Lutherans Novartis Ag Transaction History

Thrivent Financial For Lutherans

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	SELL	$80.03 - $92.81 $5,922 - $6,867	-74 Reduced 3.12%	2,301 $212,000
Q4 2022 Feb 08, 2023	BUY	$75.55 - $92.52 $179,431 - $219,735	2,375 New	2,375 $215,000
Q2 2022 Aug 16, 2022	SELL	$80.52 - $93.75 $244,861 - $285,093	-3,041 Reduced 56.15%	2,375 $201,000
Q1 2022 May 13, 2022	BUY	$80.11 - $90.62 $433,875 - $490,797	5,416 New	5,416 $475,000
Q1 2021 May 17, 2021	SELL	$83.5 - $98.47 $224,531 - $264,785	-2,689 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $209,930 - $253,922	2,689 New	2,689 $254,000
Q3 2020 Nov 10, 2020	SELL	$82.14 - $91.0 $223,667 - $247,793	-2,723 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$70.67 - $99.01 $23,109 - $32,376	327 Added 13.65%	2,723 $225,000
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $138,080 - $156,120	-1,637 Reduced 40.59%	2,396 $227,000
Q3 2019 Nov 14, 2019	BUY	$85.54 - $94.26 $344,982 - $380,150	4,033 New	4,033 $350,000
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $4,339 - $4,658	-60 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$74.14 - $77.27 $4,448 - $4,636	60	60 $5,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.